Scarica l'app Stockscreener
4.32
7.30%
-0.34
Dopo l'orario di chiusura:
4.32
Precedente Chiudi:
$4.66
Aprire:
$4.64
Volume 24 ore:
431.30K
Relative Volume:
0.48
Capitalizzazione di mercato:
$280.25M
Reddito:
$207.32M
Utile/perdita netta:
$-61.04M
Rapporto P/E:
-4.5108
EPS:
-0.9577
Flusso di cassa netto:
$-25.97M
1 W Prestazione:
+2.61%
1M Prestazione:
+2.13%
6M Prestazione:
+48.97%
1 anno Prestazione:
-30.43%
Intervallo 1D:
$4.27
$4.64
Intervallo di 1 settimana:
$4.1317
$4.70
Portata 52W:
$1.17
$7.78
Treace Medical Concepts Inc Stock (TMCI) Company Profile
Nome
Treace Medical Concepts Inc
Settore
Industria
Telefono
(904) 373-5940
Indirizzo
100 PALMETTO PARK PLACE, PONTE VEDRA
Compare TMCI vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
TMCI
Treace Medical Concepts Inc
|
4.32 | 280.25M | 207.32M | -61.04M | -25.97M | -0.9577 |
ABT
Abbott Laboratories
|
93.93 | 163.61B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
329.78 | 126.42B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
83.87 | 107.36B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.77 | 66.54B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
92.21 | 53.09B | 6.30B | 1.07B | 1.09B | 1.8406 |
Treace Medical Concepts Inc Stock (TMCI) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-11-07 | Downgrade | BTIG Research | Buy → Neutral |
| 2025-11-07 | Downgrade | JP Morgan | Neutral → Underweight |
| 2025-02-04 | Aggiornamento | BTIG Research | Neutral → Buy |
| 2024-12-31 | Iniziato | Lake Street | Buy |
| 2024-12-17 | Ripresa | JP Morgan | Neutral |
| 2024-05-16 | Downgrade | UBS | Buy → Neutral |
| 2024-05-08 | Downgrade | BTIG Research | Buy → Neutral |
| 2024-05-08 | Downgrade | JP Morgan | Overweight → Neutral |
| 2024-05-08 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-05-08 | Downgrade | Stifel | Buy → Hold |
| 2024-05-08 | Downgrade | Truist | Buy → Hold |
| 2023-09-29 | Iniziato | UBS | Buy |
| 2023-05-01 | Iniziato | Truist | Buy |
| 2023-04-11 | Iniziato | Stephens | Equal-Weight |
| 2022-05-12 | Iniziato | BTIG Research | Buy |
| 2022-01-07 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2021-05-18 | Iniziato | JP Morgan | Overweight |
| 2021-05-18 | Iniziato | Morgan Stanley | Equal-Weight |
| 2021-05-18 | Iniziato | SVB Leerink | Outperform |
| 2021-05-18 | Iniziato | Stifel | Buy |
Mostra tutto
Treace Medical Concepts Inc Borsa (TMCI) Ultime notizie
3 Penny Stocks With Market Caps Under $900M To Watch - simplywall.st
TMCITreace Medical Concepts Inc Earnings - Finviz
Treace Medical Concepts, Inc.(NasdaqGS:TMCI) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Treace Medical Concepts, Inc.(NasdaqGS:TMCI) dropped from Russell 2500 Growth Benchmark - marketscreener.com
Treace Medical Concepts, Inc.(NasdaqGS: TMCI) dropped from Russell 2000 Index - marketscreener.com
Treace Medical Concepts, Inc.(NasdaqGS:TMCI) added to Russell Microcap Growth Benchmark Index - marketscreener.com
Treace Medical Concepts, Inc.(NasdaqGS:TMCI) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Bronstein, Gewirtz & Grossman, LLC Is Investigating Treace Medica - The National Law Review
Treace Medical Concepts, Inc. (TMCI) Investigation: Bronstein, Ge - The National Law Review
Levi & Korsinsky Notifies Treace Medical Concepts, Inc. (TMCI) InvestorsLead Plaintiff Deadline on June 10, 2025 - The National Law Review
Treace Medical Concepts Inc (TMCI) Valuation: PE, PB & Fair Value Analysis - TradingKey
Analysts Are Updating Their Treace Medical Concepts, Inc. (NASDAQ:TMCI) Estimates After Its First-Quarter Results - 富途牛牛
Enterprise value to revenue forward of Treace Medical Concepts, Inc. – NASDAQ:TMCI - TradingView
Price to earnings forward of Treace Medical Concepts, Inc. – NASDAQ:TMCI - TradingView
Price to earnings forward of Treace Medical Concepts, Inc. – BOATS:TMCI - TradingView
Price to sales forward of Treace Medical Concepts, Inc. – NASDAQ:TMCI - TradingView
Enterprise value to EBITDA forward of Treace Medical Concepts, Inc. – NASDAQ:TMCI - TradingView
Enterprise value to EBITDA forward of Treace Medical Concepts, Inc. – BOATS:TMCI - TradingView
Treace Medical Concepts Inc (TMCI) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Treace Medical Concepts (TMCI) Q3 2024 earnings summary - Quartr
Treace Medical Concepts (TMCI) Q2 2024 earnings summary - Quartr
Treace Medical Concepts (TMCI) Q1 2026 earnings summary - Quartr
Treace Medical Concepts (TMCI) Proxy filing Summary - Quartr
Treace Medical Concepts (TMCI) Sidoti Small-Cap Virtual Investor Conference Summary - Quartr
Treace Announces First Surgical Case with the HyperPlate™ XM Dynamic Compression Locking Implant System - GlobeNewswire
Treace Medical Concepts Inc - TradingKey
Treace Medical Concepts Inc (TMCI) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Treace treats its first patient with HyperPlate XM foot implant - Stock Titan
Treace Medical Concepts Inc (TMCI) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Treace Medical Concepts Inc (TMCI) Institutional Confidence - TradingKey
Treace Medical Concepts Inc (TMCI) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Treace Medical Concepts Inc (TMCI) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Treace Medical Concepts Inc (TMCI) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Treace Medical Concepts Inc. (TMCI) Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Modest Share UptickAnalyst Drop Coverage - dars.gov.et
Treace Medical Concepts Balances Growth With Earnings Strain - TipRanks
Treace Medical Concepts CEO John T. Treace buys $99,195 in stock - Investing.com UK
Treace Medical Concepts CEO John T. Treace buys $99,195 in stock By Investing.com - Investing.com South Africa
Treace Medical (TMCI) CEO boosts direct stake with June share buys - Stock Titan
Treace Medical Concepts CEO John T. Treace buys $210,967 in stock By Investing.com - Investing.com Australia
Treace Medical Concepts CEO John T. Treace buys $210,967 in stock - Investing.com
Treace Medical (NASDAQ: TMCI) CEO adds 52,317 shares in open-market purchases - Stock Titan
Treace to Present at the Sidoti Small Cap Conference - The Manila Times
Treace to showcase bunion surgery tech at Sidoti Small Cap Conference - Stock Titan
TMCI Q1 2026 Earnings: Narrowed Loss Beats Expectations Amidst Operational FocusEarnings Call Transcript - newsline.com
Treace Medical CEO John Treace buys $177,915 in company stock By Investing.com - Investing.com Nigeria
Treace Medical CEO John Treace buys $177,915 in company stock - Investing.com
Treace Medical (TMCI) CEO buys 50,000 shares in open-market trade - Stock Titan
Treace Medical (NASDAQ:TMCI) CEO John Treace acquires $340,588 in shares - Investing.com Australia
Treace Medical Concepts Insider Bought Shares Worth $340,589, According to a Recent SEC Filing - marketscreener.com
Treace Medical Concepts (TMCI) CEO buys 115,520 shares of stock - Stock Titan
Treace Medical Concepts (TMCI) Surges 6% as Shares Test Key Resistance LevelStock Surge Alerts - dars.gov.et
Treace Medical Concepts Inc Azioni (TMCI) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
2.36%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):